Search Details

Word: rosenfelds (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...were the NBA commissioner, what would you do to provide a better support system, especially for the younger players? Jesse Rosenfeld, NEW YORK CITY...

Author: /time Magazine | Title: 10 Questions for LeBron James | 7/12/2007 | See Source »

...We’re not getting reports. All of them ended in September.” Students, however, say they have been vocal about the vermin their midst. “There are always plenty of complaints about the [cockroach] issue,” Jessica R. Rosenfeld ’07 wrote in an e-mail. Rosenfeld, herself a former Lowell resident, is currently taking a semester abroad in Argentina, but felt strongly enough about the cause contra cockroaches to write a letter to The Crimson in late September decrying the College’s handling of the pest problem...

Author: By Christian B. Flow, CRIMSON STAFF WRITER | Title: Lowell Will Put An End to Pests | 12/19/2006 | See Source »

...leave Lowell House for my last semester on campus. Perhaps if there was more publicity, administrators would take more notice and actually try to solve the problem once and for all. Shouldn’t over $40,000 a year buy you a room without vermin? JESSICA R. ROSENFELD ’07 September...

Author: By Jessica R. Rosenfeld, | Title: Harvard Must Do More To Eradicate Campus Pests | 9/29/2006 | See Source »

...only problem? Lucentis will likely cost more than 100 times as much as the temporary fix.??A dose of Avastin for the eye costs as little as $13, says Rosenfeld, who is also a lead author on Lucentis trial reports. (Using FDA-approved drugs for "off-label" uses is??common practice, especially in ophthalmology.) Lucentis is almost certain to be pricier when Genentech announces the U.S. sales tag: competing treatments cost up to $3000 per dose...

Author: /time Magazine | Title: A Retina Drug Prompts Big Hopes ? and Potentially Big Costs | 6/29/2006 | See Source »

...When Lucentis is approved, it is doubtful Americans will continue to use Avastin for AMD - even though the cheaper drug has worked so well that some 30 states now cover it for macular-degeneration treatment, says Rosenfeld. Doctors predict patients will go for the drug that has the FDA imprimatur, as long as insurance companies pick up the higher cost. Doctors too will most likely turn to the more expensive drug. "Let's just say there's a bad outcome," says Dr. John Sorenson, an AMD expert in New York City. "You can already hear the lawyers say, 'Doctor...

Author: /time Magazine | Title: A Retina Drug Prompts Big Hopes ? and Potentially Big Costs | 6/29/2006 | See Source »

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | Next